Inhibition of CRAC with a human anti-ORAI1 monoclonal antibody inhibits T-cell-derived cytokine production but fails to inhibit a T-cell-dependent antibody response in the cynomolgus monkey-Reference-Cited by-同舟云学术

Inhibition of CRAC with a human anti-ORAI1 monoclonal antibody inhibits T-cell-derived cytokine production but fails to inhibit a T-cell-dependent antibody response in the cynomolgus monkey

Published:2014-07-03 Issue:2 Volume:12 Page:164-173
ISSN:1547-691X
Container-title:Journal of Immunotoxicology
language:en
Short-container-title:Journal of Immunotoxicology

Author:

Gaida Kevin,Salimi-Moosavi Hossein,Subramanian Raju,Almon Valerie,Knize Anna,Zhang Ming,Lin Fen-Fen,Nguyen Hung Q.,Zhou Lei,Sullivan John K.,Wong Min,McBride Helen J.

Publisher

Informa UK Limited

Subject

Toxicology,Immunology

Link

http://www.tandfonline.com/doi/pdf/10.3109/1547691X.2014.915897

Reference38 articles.

1. Role of nuclear factor of activated T cells (NFAT) in the expression of interleukin-5 and other cytokines involved in the regulation of hemopoetic cells

2. Calcium signalling in lymphocyte activation and disease

3. ORAI1 and STIM1 deficiency in human and mice: roles of store-operated Ca2+entry in the immune system and beyond

4. Immunodeficiency due to defects in store-operated calcium entry

5. Gene regulation mediated by calcium signals in T lymphocytes

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ORAI Ca2+ Channels in Cancers and Therapeutic Interventions;Biomolecules;2024-03-29

2. ORAI1 inhibition as an efficient preclinical therapy for tubular aggregate myopathy and Stormorken syndrome;JCI Insight;2024-03-05

3. T Cell-Dependent Antibody Response Assay: Biology, Methods, and Application;Reference Module in Biomedical Sciences;2024

4. Store-Operated Ca2+ Channels: Mechanism, Function, Pharmacology, and Therapeutic Targets;Annual Review of Pharmacology and Toxicology;2021-01-06

5. Anti‐ORAI1 antibody DS‐2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T‐cell and mast cell activation;FASEB BioAdvances;2020-07-08